Document ID: chunk:federal_register_of_legislation:F2024L01389:schedule:1:p52
Version: federal_register_of_legislation:F2024L01389
Segment Type: schedule
Provision Reference: sch 1 (pt 52/66)
Character Range: 157467–163712

be in combination with non-pharmacological measures;
                                                      Patient must be at least 18 years of age.
                                                      Behaviour disturbances are defined as severe aggression and injuries to self or others where non-pharmacological methods alone have been unsuccessful.
                                                      The diagnosis of autism spectrum disorder must be made based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) or ICD-10 international classification of mental and behavioural disorders.
C16050  P16050  CN16050  Buprenorphine                Opioid dependence                                                                                                                                                                                                                                                                                                                                                                                                   Compliance with Authority Required procedures - Streamlined Authority Code 16050
                                                      Must be treated by a health care professional; AND
                                                      The treatment must be within a framework of medical, social and psychological treatment; AND
                                                      Patient must be stabilised on sublingual buprenorphine or buprenorphine/naloxone prior to commencing treatment with this drug for this condition.
                                                      The prescriber must not request the maximum listed quantity or number of repeats if lesser quantity or repeats are sufficient for the patient's needs.
C16051  P16051  CN16051  Buprenorphine                Opioid dependence                                                                                                                                                                                                                                                                                                                                                                                                   Compliance with Authority Required procedures - Streamlined Authority Code 16051
                                                      Must be treated by a health care professional; AND
                                                      The treatment must be within a framework of medical, social and psychological treatment.
                                                      The prescriber must not request the maximum listed quantity or number of repeats if lesser quantity or repeats are sufficient for the patient's needs.
C16053  P16053  CN16053  Avelumab                     Stage IV (metastatic) Merkel Cell Carcinoma                                                                                                                                                                                                                                                                                                                                                                         Compliance with Authority Required procedures - Streamlined Authority Code 16053
                                                      Initial treatment
                                                      The treatment must be the sole PBS-subsidised therapy for this condition; AND
                                                      The treatment must not exceed a total of 9 doses at a maximum dose of 10 mg per kg every 2 weeks under this restriction. or
                                                      The treatment must not exceed a dose of 800 mg every 2 weeks under this restriction.
                                                      The patient's body weight must be documented in the patient's medical records at the time treatment is initiated.
C16054  P16054  CN16054  Chlormethine                 Mycosis fungoides cutaneous T-cell lymphoma                                                                                                                                                                                                                                                                                                                                                                         Compliance with Authority Required procedures
                                                      Continuing treatment
                                                      Patient must have previously received PBS-subsidised treatment with this drug for this condition; AND
                                                      Patient must not have developed disease progression while receiving PBS-subsidised treatment with this drug for this condition; AND
                                                      Patient must be treated by at least one of the following prescriber types (i) dermatologist, (ii) haematologist; AND
                                                      The treatment must be approved for 1 unit if the condition is no more than 10% of the patient's body surface area to provide 4 weeks of treatment per script. or
                                                      The treatment must be approved for 2 units if the condition is no more than 25% of the patient's body surface area to provide 4 weeks of treatment per script.
C16055  P16055  CN16055  Lanreotide                   Acromegaly                                                                                                                                                                                                                                                                                                                                                                                                          Compliance with Authority Required procedures - Streamlined Authority Code 16055
                                                      Continuing treatment
                                                      Patient must